Westpac Banking Corp
WBC
Woodside Energy Group Ltd
WDS
CommBank
CBA
ANZ Group Holdings Ltd
ANZ
National Australia Bank Ltd
NAB
AdAlta Ltd is engaged in drug discovery and development company developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis, and CAR-T cancer therapeutics.